🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial compares the effects, good and/or bad of abiraterone an...
Status
Recruiting
Location
University of California Davis Comprehensive Cancer Center
Start Date
2023-11-09
Trial ID
NCT06173362
Treatments Being Tested
Researchers are looking for a better way to treat men who have biochemicall...
Status
Completed
Location
Unio Specialty Care - Urology - Sherman Oaks
Start Date
2022-12-19
Trial ID
NCT05526248
Treatments Being Tested
The purpose of the study is to assess if the addition of darolutamide to AD...
Status
Active Not Recruiting
Location
Urology Centers of Alabama, PC - Homewood
Start Date
2021-11-04
Trial ID
NCT05059236
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of BAY184178...
Status
Completed
Location
Multiple Locations
Start Date
2014-09-12
Trial ID
NCT02200614
Treatments Being Tested
This phase II trial studies the effects of stereotactic body radiation ther...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2024-06-03
Trial ID
NCT06378866
Treatments Being Tested
This is an observational study in which participants receive a treatment wh...
Status
Recruiting
Location
Many locations
Start Date
2024-09-25
Trial ID
NCT06334120
Treatments Being Tested
This is an international, prospective, open-label, multicenter, multi-cohor...
Status
Active Not Recruiting
Location
Many Locations
Start Date
2026-01-29
Trial ID
NCT07344779
Treatments Being Tested
In this observational study, participants receive darolutamide: a treatment...
Status
Recruiting
Location
Many locations
Start Date
2026-07-31
Trial ID
NCT07538843
Treatments Being Tested
This phase III trial uses the Decipher risk score to guide therapy selectio...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2021-12-06
Trial ID
NCT05050084
This phase II trial compares the effect of adding darolutamide to standard ...
Status
Recruiting
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2025-09-09
Trial ID
NCT07016399